02 March 2021 | News
The two organisations have been working together to deliver world-class clinical research services to Avance Clinical's biotech customers via the Medidata Rave Clinical Cloud™
The leading Australian CRO for biotechs, and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner, Avance Clinical continues to celebrate their strategic partnership with Medidata, and the accreditation of seven Medidata in-house experts.
The two organisations have been working together to deliver world-class clinical research services to Avance Clinical's biotech customers via the Medidata Rave Clinical Cloud™.
Ben Edwards, Chief Strategy Officer, Avance Clinical, said, “We look forward to many more years working with Medidata as we continue to grow the business and support the development needs of our clients."
Edwin Ng, Senior Vice President, General Manager, Medidata APAC, said, "We are pleased to be supporting Avance Clinical's exceptional growth in Australia. Avance Clinical accreditation signifies the importance of Medidata's portfolio of products in ensuring the success of our partners' programmes, and our continued commitment to helping our partners streamline and enhance the clinical research process."
Sandrien Louwaars, Director Business Development Operations, Avance Clinical, said, "The Medidata Rave Clinical Cloud™ is a quality- and efficiency-focused unified platform that helps our biotech clients, and ensures data integrity, speed, and compliance across multisite and global studies. Our seven Avance Clinical accredited Medidata experts lead our efforts, and it makes a real difference for our clients having them in-house rather than as external consultants.”